Chemical Medicine Department

              
 
Chemical Medicine Department was established in February 2001.

Taking R&D strategy of 'combining imitation with creation', the institute dedicated itself to the exploration of non-patent medicine and exclusive preparations. It features in developing chiral intermediate product in the fields concerning nucleotide, amylose, and polypeptide. The institute loses no opportunity to conduct research on medical innovation or to build up R&D platform for synthetic medicine and technological platform for technique optimization on preparations. The goal is to become the pioneer of new medicine R&D in China:

1.Chiral medicine and metabolin research is not only the developing tendency abroad, but also a brand-new field for medical research in China. Now the newly developed medicines all belong to this field.

2.Building up R&D platform for synthetic medicine and technological platform for technique optimization on preparations, and realizing the application of synthesis technique including stereoselective synthesis, high pressure catalytic hydrogenation reaction, moisture free and oxygen free reaction, and reaction under ultralow temperature.

3.Research on non-patent medicine is the direction of the Department. It adopts new techniques and new preparations, conducts creative innovation on non-patent medicine, and seizes the overseas market via new products.
022-86342893